Health
SK Bioscience embarks on clinical test of COVID-19 vaccine candidate NBP2001 – Aju Business Daily
[Courtesy of SK Bioscience]SEOUL — SK Bioscience, a cooperation partner for South Koreas state project to develop COVID-19 vaccines, will immediately embark on…
[Courtesy of SK Bioscience]
SEOUL — SK Bioscience, a cooperation partner for South Korea’s state project to develop COVID-19 vaccines, will immediately embark on the first phase of clinical trials to evaluate the safety and immunogenicity of its vaccine candidate called NBP2001. The first test will be conducted on healthy adults at a state-run hospital.The Ministry of Food and Drug Safety said that SK Bioscience has been allowed to carry out clinical trials of NBP2001, a recombinant vaccine manufactured…
-
General20 hours agoEmergency operation underway after reports of bodies north-east of Falls Creek
-
Noosa News23 hours agoRetail worker allegedly raped at gunpoint before 3½-hour kidnapping ordeal
-
Noosa News21 hours agoMan arrested after gaining ‘unauthorised’ access to Amberley RAAF base
-
Noosa News22 hours agoPSPA declared, Camp Mountain – Sunshine Coast